MedTrace Logo

Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis

NCT05008263 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2021-08-17

No results posted yet for this study

Summary

The study "Competitive Accuracy of Radiological Imaging Compared to Liver Biopsy in Patients With Liver Fibrosis" is designed to test the accuracy of non-interventional radiological imaging and compare its results with the "gold standard" liver biopsy. This is prospective non-randomized single patient group study.

Conditions

Interventions

DIAGNOSTIC_TEST

Liver elastography (2D-SWE)

All patients were referred for 2D-SWE liver elastography and liver liver scintigraphy with 99mTc-mebrofenin prior to liver biopsy.

DIAGNOSTIC_TEST

Liver scintigraphy with 99mTc-mebrofenin

All patients were referred for 2D-SWE liver elastography and liver liver scintigraphy with 99mTc-mebrofenin prior to liver biopsy.

Sponsors & Collaborators

  • Vilnius University

    lead OTHER

Principal Investigators

  • Algirdas E Tamosiunas, MD, PhD · Vilnius University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2020-01-31
Completion
2020-01-31

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05008263 on ClinicalTrials.gov